Erratum: Analysis of mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection (PLoS ONE (2009) 4:5 (e5528) DOI:10.1371/journal.pone.0005528);Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Caccamo, Nadia ^a   Guggino, Giuliana ^a   Meraviglia, Serena ^a   Gelsomino, Giuseppe ^a   Di Carlo, Paola ^a   Titone, Lucina ^a   Bocchino, Marialuisa ^b   Galati, Domenico ^b   Matarese, Alessandro ^b   Nouta, Jan ^c   Klein, Michel R ^d   Salerno, Alfredo ^a   Sanduzzi, Alessandro ^b   Dieli, Francesco ^a   Ottenhoff, Tom H M ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HLA A ANTIGEN; INTERLEUKIN 2; CYTOKINE; EPITOPE; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE FREQUENCY; HLA SYSTEM; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; INFECTION CONTROL; INNATE IMMUNITY; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; TUBERCULOSIS; BLOOD; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY;

MYCOBACTERIUM TUBERCULOSIS;

CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A ANTIGENS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; TUBERCULOSIS;

EID: 65849488547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0223028     Document Type: Erratum

References (39)

1. WHO (2008) Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: World Health Organization, Available at http:// www.who.int/entity/tb/publications/global_report/2008/pdf/fullreport.pdf.
2. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 89: 12013-12017.
3. + T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect Immun 67: 1034-1044.
4. Koga T, Wand-Wurttenberger A, DeBruyn J, Munk ME, Schoel B, et al. (1989) T cells against a bacterial heat shock protein recognize stressed macrophages. Science 4922: 1112-1115.
5. Stenger S, Mazzaccaro RJ, Uyemura K, Cho S, Barnes PF, et al. (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276: 1684-1687.
6. + T cells in human tuberculosis. Proc Natl Acad Sci U S A 97: 12210-5.
7. Kaufmann SH, McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11: S33-44.
8. Flynn JL, Chan J (2001) Tuberculosis: latency and reactivation. Infect Immun 69: 4195-201.
9. + T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 95: 270-275.
10. Ottenhoff THM, Lewinsohn DA, Lewinsohn DM (2008) Human CD4 and CD8 T cell responses to Mycobacterium tuberculosis: antigen specificity, function, implications and applications. Handbook of Tuberculosis. Immunology and Cell Biology. Kaufmann SHE, Britton WJ, eds. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co.KGaA.
11. Klein MR, Fox A (2001) Mycobacterium-specific human CD8 T cell responses. Arch Immunol Ther Exp (Warsz) 49: 379-89.
12. Tully G, Kortsik C, Höhn H, Zehbe I, Hitzler WE, et al. (2005) Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol 174: 2174-84.
13. Gambon-Deza F, Pacheco Carracedo F, Cerda Mota T, Montes Santiago J (1995) Lymphocyte populations during tuberculosis infection: V repertoires. Infect Immun 63: 1235-40.
14. Caccamo N, Meraviglia S, La Mendola C, Guggino G, Dieli F, et al. (2006) Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J Immunol 177(3): 1780-5.
15. + effector T cells in childhood tuberculosis. J Immunol 179: 1331-9.
16. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101: 4260-66.
17. Hammond AS, Klein MR, Corrah T, Fox A, Jaye A, et al. (2005) Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes. Clin Exp Immunol 140: 109-16.
18. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, et al. (2007) Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 178: 5217-26.
19. Dieli F, Singh M, Spallek R, Romano A, Titone L, et al. (2000) Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand J Immunol 52: 96-102.
20. Dieli F, Friscia G, Di Sano C, Ivanyi J, Singh M, et al. (1999) Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J Infect Dis 180: 225-28.
21. + T cells during persistent infection. Blood 15;106(2): 558-65.
22. Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8(4): 247-58.
23. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, et al. (2006) Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211: 236-54.
24. Pantaleo G, Koup RA (2004) Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 10: 806-10.
25. Soares AP, Scriba TJ, Joseph S, Harbacheuski R, Murray RA, et al. (2008) Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 180: 3569-3577.
26. Diagnostic standards and classification of tuberculosis in adults and children: this official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July (1999) This statement was endorsed by the Council of the Infectious Disease Society of America, September (1999). Am J Respir Crit Care Med 161: 20001376-1395.
27. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, et al. (2004) Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 38: 754-756.
28. Di Liberto D, Buccheri S, Caccamo N, Meraviglia S, Romano A, et al. (2007) Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis 87: 322-328.
29. Dieli F, Sireci G, Caccamo N, Di Sano C, Titone L, et al. (2002) Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J Infect Dis 186: 1835-1839.
30. Menzies D (1999) Interpretation of repeated tuberculin tests: boosting, conversion and reversion. Am J Respir Crit Care Med 159: 15-21.
31. Richeldi L (2006) An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174: 736-742.
32. Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
33. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2 peptide complexes: Refolding and crystallization of molecules expressed in E. coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89: 3429.
34. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-9.
35. + T cells in HLA-transgenic mice and humans. J Immunol 165: 6463-6471.
36. Geluk A, van Meijgaarden KE, Drijfhout JW, Ottenhoff TH (1995) Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs. Mol Immunol 32: 975-981.
37. Teixeira A, Benckhuijsen WE, de Koning PE, Valentijn AR, Drijfhout JW (2002) The use of DODT as a non-malodorous scavenger in Fmoc-based peptide synthesis. Protein Pept Lett 9: 379-385.
38. Klein MR, Hammond AS, Smith SM, Jaye A, Lukey PT, et al. (2002) HLAB* 35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c. Infect Immun 70: 981-4.
39. D'Amaro J, Houbiers JG, Drijfhout JW, Brandt RM, Schipper R, et al. (1995) A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide binding motifs. Hum Immunol 43: 13-8.